Bacteria found in Alzheimer patients' brain tissue helps clarify the effectiveness of infrared phototherapy
Bacteria now identified in the brains of people struggling with memory loss has been established now in the research findings of a research group at the University of Bristol in the UK led by Dr. David Emery. This finding reinforces the position Quietmind has taken around the utility of near infrared light stimulation for the treatment of neurodegeneration. Clinical trials are now underway at Quietmind's research center in Elkins Park, PA. Call for details 610-940-0488
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.
Monday & Thursday: 11am - 6pm
remote conferencing available
Main Office- PA
8120 Old York Road, Suite 140
Elkins Park, PA 19027
New York Office
1619 3rd Ave. Suite 202 New York, NY 10128
(clinical trial evaluation only)
QuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.